About Baymatob
Baymatob is an Australian healthcare AI company focused on transforming maternal and fetal health outcomes through its AI-guided maternity sensor, monitoring, and diagnostic platform called Oli. The company aims to address the significant challenges in maternal care, where current monitoring technologies are often decades old and fail to provide early warnings for critical complications. Oli is designed to empower healthcare providers by acquiring, interpreting, and predicting vital information about pregnancy progression and potential risks to both mothers and babies.
Specifically, Baymatob’s flagship product, Oli PPH, is being developed to identify individuals at a higher risk of developing postpartum hemorrhage (PPH) well before birth. PPH is a leading cause of preventable maternal death globally, and Oli PPH aims to provide essential advance warning, potentially an hour prior to blood loss, to allow for proactive clinical interventions and reduce the severity of outcomes such as emergency hysterectomy. The device is a wearable sensor that adheres to the mother’s abdomen, monitoring physiological signals including biopotentials, movement, temperature, and deformation. This technology has received FDA Breakthrough Device Designation, indicating its potential to significantly improve clinical practice. Beyond PPH, Baymatob envisions Oli as a comprehensive platform capable of providing insights into labor onset, time until birth, and early warnings for stillbirth, ultimately aiming to establish a new standard of care in maternal health.
Focus Areas
Business Intelligence
| Technology | AI-guided wearable sensor and diagnostics platform, cloud-connected digital platform |
What Physicians Need to Know
For physicians, Baymatob's Oli platform offers an unprecedented opportunity to move from reactive to proactive care in maternal health. The AI-guided sensor provides real-time, actionable insights and early warnings for critical complications like postpartum hemorrhage, potentially hours before traditional methods. This allows for crucial time to prepare and implement preventative measures, improving workflow efficiency and ultimately leading to safer outcomes for mothers and babies. The non-invasive and user-friendly design also supports women's choices in birth and integrates seamlessly into existing clinical workflows.
While specific integration partners are not detailed, the Oli platform is designed to be a digital platform that uses AI as an enhancement tool. Its ability to provide real-time data and insights suggests potential for integration with existing electronic health record (EHR) systems and other hospital monitoring platforms to streamline data flow and clinical decision-making. The company's focus on expanding equity of access also implies potential for integrations that support remote monitoring and community-based care.
What the Web Says
Baymatob is an Australian medical device company focused on improving maternal and fetal health outcomes, particularly by developing a wearable AI-guided device called 'Oli' to predict postpartum hemorrhage (PPH) before birth. The company has completed a 500-patient pilot study for Oli and received Breakthrough Device designation from the US FDA, indicating its potential to transform clinical practice. Reviews for Baymatob itself are limited on major review platforms like G2, Glassdoor, Capterra, and Reddit, with most search results pointing to other companies with similar names. However, information available suggests a positive outlook on their product and mission.
Overall: PositiveStrengths
- Oli device has received US FDA Breakthrough Device designation, expediting regulatory review.
- The company's mission is to radically reduce postpartum hemorrhage (PPH) and improve maternal and fetal health.
- Oli is designed to provide early warnings for severe complications during pregnancy and labor.
- The device uses innovative sensor technology and AI for comprehensive maternal and fetal monitoring.
- Baymatob is described as having a team of passionate and diverse individuals.
- The company aims to transform and reinvent pregnancy and labor healthcare.
Limitations
- Limited public reviews available for Baymatob as an employer or for its product, Oli, on common review platforms like G2, Glassdoor, Capterra, and Reddit.
- No specific negative feedback found in the provided search results regarding Baymatob or its product.
- The Oli device is still in clinical trials and not yet widely available.
Based on reviews from: Alberts, BioSpace, PR Newswire, The University of Sydney, GlobalData
Last updated: 2026-09-19
Videos
News, demos, and interviews about Baymatob.
Videos load interactively. If none appear, search YouTube for Baymatob →
Press & Coverage
Frequently Asked Questions
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
TimeDoc Health is a healthcare technology and services company that provides virtual care management solutions, primarily focusing on chronic care management (CCM), remote patient monitoring (RPM), and behavioral health integration (BHI). Their platform and services are designed to help healthcare organizations, including primary care providers, health systems, FQHCs (Federally Qualified Health Centers), and Medicare Advantage […]
Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]
PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]